A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5377 (2006.01) A61K 9/14 (2006.01) A61K 9/16 (2006.01)
Patent
CA 2469315
The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4- fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.
Cette invention a trait à de nouvelles compositions pharmaceutiques à base du composé suivant : 2-(R)-(1-(R)-(3,5-bis(trifluorométhyl)phényl)éthoxy)-3-(S)-(4-fluoro)phényl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)méthylmorpholine. Ces compositions pharmaceutiques se révèlent des plus utiles dans le traitement ou la prévention d'états pathologiques tels que des troubles psychiques, parmi lesquels la dépression et l'angoisse, ainsi que de maladies inflammatoires et de vomissements.
Bosch H. William
Liversidge Elaine
Shelukar Suhas D.
Thompson Karen C.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Pharmaceutical nanoparticulate composition of a tachykinin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical nanoparticulate composition of a tachykinin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical nanoparticulate composition of a tachykinin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1746746